Psilocybin therapy for bipolar II depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether psilocybin (a substance found in certain mushrooms) given with therapy can help people with bipolar II disorder who are currently in a major depression that hasn't responded to other treatments. You'll receive the drug in a supportive setting, and researchers will follow your progress to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 65 years old.
- You have bipolar II disorder and are currently in a major depressive episode.
- You are willing to use effective birth control or abstain from sex during the study if you could become pregnant or get someone pregnant.
- You can read and speak English well enough to understand the study and follow instructions.
- Your current medications have been stable for at least 2 weeks before the dosing visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if two doses of psilocybin, given under medical supervision, are safe and acceptable for people with Bipolar II disorder who have mild to moderate depression and certain suicidal thoughts. The goal is to see if it may help improve mood and reduce suicidal thinking.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
Hear when a new Bipolar II Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.